Skip to main content

NASA’s Juno spacecraft has captured some stunning imagery of Jupiter since entering

While NASA’s Juno spacecraft has captured some stunning imagery of Jupiter since entering orbit around the gas giant in 2016, it’s not the only celestial body in the probe’s sights. As part of its exploration of the Jovian system, Juno is also inspecting one of planet’s largest moons in Europa, and has this week swooped in for its closest look yet.

Europa is a source of much intrigue for scientists on the hunt for life beyond Earth. For years, researchers have been watching the moon closely from afar and evidence of liquid water has begun to build, adding weight to the theory that a subsurface ocean lies beneath its icy shell.

This salty body of water is thought to be one the most likely places to harbor life in our Solar System, and with its advanced suite of imagers and instruments, Juno may just help us dig into these secrets. On Thursday September 29, the probe came within 219 miles (352 km) of the moon’s surface, and was the first spacecraft to fly this close to Europa since the Galileo probe in 2000.

In doing so, Juno captured what are some of the highest-resolution images of Europa to date, at around 1 km (0.6 miles) per pixel, along with new data on its icy shell and subsurface structure. The first of these images has now made its way back to Earth, and was snapped around 1,500 km (930 miles) from the surface as Juno zeroed in.

Comments

Popular posts from this blog

deploying chemotherapy to hold the tumor cells

Engineers at Duke University have developed a novel delivery system for cancer treatment and demonstrated its potential against one of the disease’s most troublesome forms. In newly published research in mice with pancreatic cancer, the scientists showed how a radioactive implant could completely eliminate tumors in the majority of the rodents, demonstrating what they say is the most effective treatment ever studied in these pre-clinical models. Pancreatic cancer is notoriously difficult to diagnose and treat, with tumor cells of this type highly evasive and loaded with mutations that make them resistant to many drugs. It accounts for just 3.2 percent of all cancers, yet is the third leading cause of cancer-related death. One way of tackling it is by deploying chemotherapy to hold the tumor cells in a state that makes them vulnerable to radiation, and then hitting the tumor with a targeted radiation beam.